Is ARRY stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Array BioPharma Inc. 10 years ago, but if you had invested on Thursday 15th of October 2020 when the price was $36.45, you would have made a loss of $-30.07 per share or -82.50%
Yes, the average daily trading liquidity for Array BioPharma Inc. is $61.56 million. You should therefore be able to get in and out of your positions relatively fast.
Array BioPharma Inc. has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.34, the company's ability to pay off the debt is normal. Array BioPharma Inc. has a good net profit margin of 8.37% and should have high tolerances against inflation.
We have calculated the inflation risk for Array BioPharma Inc. to be low [0.4 out of 1]